PharmaReports: Cardiovascular Disorders
LeadDiscovery offers full reports in selected areas of the pharmaceutical and biotech sector.
Each of the reports below has been especially selected by LeadDiscovery. Browse the reports or try our search engine.
Reports relating to all aspects of cardiovascular disease are included here with the exception of those relating to neurodegenerative components of stroke. Reports with a focus on atherosclerosis are also included here
Showing results 1 - 50 of 132
- Biomarkers: A Market Briefing
- Blood: The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products
- The Protein Therapeutics Market: The Science and Business of a Growing Sector
- Critical Care Pharmaceutical Markets: A Strategic Analysis
- Medical Imaging Markets: Radiography
- The Global Market for Adjunctive Therapies in Cancer
- The Impact of the Phase III Pipeline: Future Projections and Market Disruptions
- Diabetes and Diabetic Complications: Major World Markets
- Nitric Oxide - Therapeutics, Markets and Companies
- Cardiovascular Drug Delivery - technologies,markets and companies
- Cardiac Marker Diagnostic Testing Markets
- Diabetes, Metabolic Syndrome and Cardiovascular Disease
- Stem Cell Markets
- Hematology Analyzer Instrumentation and Reagent Markets
- The World Hypertension Market 2005-2010
- Cardiac Rhythm Management Devices World Markets: Defibrillators, Pacemakers and Leads
- The Cardiovascular Market Outlook to 2011
- Early Toxicology: Markets and Approaches
- Pipeline Insight: Antithrombotics - Reaching the untreated prophylaxis market
- Atherosclerosis - HDL, ApoA-I, Carotid MRI and 64-slice CT offer opportunities
- Antithrombotics - Pipeline products to dampen the impact of patent expiries and cost containment initiatives
- Biotech Drug Delivery Systems - Key Company Intelligence & Market Outlook to 2012
- Atrial Fibrillation - Limited efficacy and poor safety lead to bleak outlook
- Antihypertensives - New challenges for a maturing market
- From Blockbuster to Nichebuster
- Pipeline Insight: Antiarrhythmics - RSD1235 in a class of its own
- Monoclonal Antibodies 2007
- The Global Protein Therapeutics Market
- Biogenerics
- Pipeline Insight: Antihypertensives - Weak pipeline leaves innovation to Novartis
- Pulmonary Arterial Hypertension - A small market gets big attention
- Drug Treatment in End-Stage Renal Disease
- Therapeutic Vaccines
- Antihypertensives - Two Years to Shape the Market?
- Hypertension - Multiple Layers of Therapy Cover all Eventualities
- Chronic and Acute Heart Failure
- Hypertension and Diabetic Kidney Disease - Prevalence, current treatment and future options
- Dyslipidemia - Statins Dominate Treatment Pathway
- Pipeline Insight: Antithrombotics - Anticoagulants and Antiplatelets Have Blockbuster Potential
- Prevention of Coronary Heart Disease - Promoting Healthy Lifestyles
- Stakeholder Insight: Heart Failure
- Stakeholder Insight: Acute Stroke
- Cancer Market Top 20 Drugs - Supportive Care Grows the Cancer Market
- Pipeline Insight: Acute Stroke - Considerable unmet need is balanced by substantial commercial risk
- Monoclonal Antibodies: Financial and strategic analysis of the mAb market
- Supportive Care in Oncology-Significant growth opportunities in new supportive care indications
- Drug Discovery Tools for High-Content Analysis
- Pipeline/Commercial Insight: Antihypertensives New class opportunity offset by key patent expiries
- Personalized Medicine
- Commercial Insight: Antidyslipidemics - The competitive cost-conscious antidyslipidemics market presents challenges
Browse our theraputic areas for other entries:
- Oncology
- Cancer Immunotherapy
- Immunology & Inflammatory Diseases
- Infectious Diseases
- Psychiatric, Addictive & Sleep Disorders
- Pain
- Neurodegenerative & Neuroelectrophysiological Disorders
- Metabolic & Hormonal Disorders
- Cardiovascular Disorders
- GenitoUrinary Tract Disorders
- Technology
- Diagnostics & Devices
- Other Theraputic Areas, Pharmaceutical Strategy and Development